CMS should subtract rebates and pharmacy fees from the prices that Medicare beneficiaries pay for drugs, but it should count them when calculating Part D coverage phases, according to West Health Policy Center . CMS has the authority to count rebates and pharmacy fees in one instance while not counting them in another, and it has already used that authority to count mandatory drug company discounts toward out-of-pocket calculations, West Health says. West Health says its recommendations would lower what...